Friday December 15, 3:05 pm Eastern Time
Press Release
SOURCE: Fountain Pharmaceuticals, Inc.
Fountain Pharmaceuticals, Inc. Announces
Resignation of President/CEO
LARGO, Fla., Dec. 15 /PRNewswire/ -- Fountain Pharmaceuticals, Inc. (OTC Bulletin Board: FPHI - news) announces that
Gerald Simmons, President & CEO, has resigned effective December 1, 2000. The Board of Directors has accepted his
resignation and will begin a search for a successor immediately.
Mr. Simmons has accepted the position of Managing Partner for The Planning Board LLC, a California-based E-Business
consulting firm specializing in e-commerce strategy and marketing communications. Mr. Simmons has been President & CEO
of Fountain since December 1998.
Fountain Pharmaceuticals, Inc. is a research-oriented company seeking to exploit topical and other applications for its
proprietary liposome technology. It markets products domestically under the LyphaZome® and Celazome® tradenames.
Fountain Pharmaceuticals is also engaged with several global partners who market LyphaZome-based products with their own
trade names under licensing agreements.
Certain statements herein that are not historical and are forward-looking statements and involve risk and uncertainties. Although
management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no
assurance that these expectations will prove to have been correct. Investors who seek more information about the company's
business and relative risk factors may wish to review the Company's periodic reports including, but not limited to, its most
recent Annual and Quarterly Reports.
SOURCE: Fountain Pharmaceuticals, Inc. |
